NO20053715D0 - 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk - Google Patents
10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykkInfo
- Publication number
- NO20053715D0 NO20053715D0 NO20053715A NO20053715A NO20053715D0 NO 20053715 D0 NO20053715 D0 NO 20053715D0 NO 20053715 A NO20053715 A NO 20053715A NO 20053715 A NO20053715 A NO 20053715A NO 20053715 D0 NO20053715 D0 NO 20053715D0
- Authority
- NO
- Norway
- Prior art keywords
- dialkylprostanoic
- agents
- acid derivatives
- intraocular pressure
- lowering intraocular
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 230000004410 intraocular pressure Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/365,369 US6875787B2 (en) | 2003-02-11 | 2003-02-11 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
US10/772,720 US20040235958A1 (en) | 2003-02-11 | 2004-02-04 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
PCT/US2004/003433 WO2004071428A2 (en) | 2003-02-11 | 2004-02-06 | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20053715D0 true NO20053715D0 (no) | 2005-08-01 |
NO20053715L NO20053715L (no) | 2005-10-27 |
NO334659B1 NO334659B1 (no) | 2014-05-12 |
Family
ID=32871611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053715A NO334659B1 (no) | 2003-02-11 | 2005-08-01 | 10,10-dialkylprostanoinsyre-derivater, fremgangsmåte for fremstilling av slike, farmasøytisk produkt omfattende slike samt anvendelse av slike som midler for å senke intraokulært trykk |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1608309B1 (no) |
JP (1) | JP5319065B2 (no) |
KR (1) | KR101077461B1 (no) |
AU (1) | AU2004211936B2 (no) |
BR (1) | BRPI0407400A (no) |
CA (1) | CA2515631C (no) |
MX (1) | MXPA05008431A (no) |
NO (1) | NO334659B1 (no) |
NZ (1) | NZ541352A (no) |
PL (1) | PL209130B1 (no) |
RU (1) | RU2336081C2 (no) |
WO (1) | WO2004071428A2 (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
JP2008518013A (ja) * | 2004-10-26 | 2008-05-29 | アラーガン、インコーポレイテッド | プロスタグランジンep4アゴニストによる処置方法およびデリバリー方法 |
AU2012200514B2 (en) * | 2005-03-17 | 2014-03-06 | Allergan, Inc. | Treatment of inflammatory bowel disease |
CN105566192B (zh) * | 2006-10-02 | 2019-01-22 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性的前列腺素及相关化合物的前药 |
EP2084124B9 (en) | 2006-10-02 | 2015-07-01 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
US8455547B2 (en) * | 2008-02-05 | 2013-06-04 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
US7732443B2 (en) * | 2008-03-18 | 2010-06-08 | Yariv Donde | Therapeutic substituted cyclopentanes |
JP2011519939A (ja) * | 2008-05-09 | 2011-07-14 | アラーガン インコーポレイテッド | 治療用化合物 |
KR20120093955A (ko) | 2009-10-14 | 2012-08-23 | 젬머스 파마 인코포레이티드 | 바이러스 감염에 대한 병용 요법 치료 |
SG187653A1 (en) * | 2010-07-30 | 2013-03-28 | Allergan Inc | Compounds and methods for skin repair |
KR20140003395A (ko) * | 2010-08-17 | 2014-01-09 | 알러간, 인코포레이티드 | 각막 혼탁 치료용 ep2 또는 ep4 항진제들 |
US20160184387A1 (en) | 2013-08-09 | 2016-06-30 | Dominique Charmot | Compounds and methods for inhibiting phosphate transport |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4117014A (en) * | 1976-01-09 | 1978-09-26 | Abbott Laboratories | Prostaglandin derivatives |
JPS59101458A (ja) * | 1982-12-01 | 1984-06-12 | Nippon Iyakuhin Kogyo Kk | 新規なチアプロスタグランジン誘導体及びその製法 |
JPS632972A (ja) * | 1986-06-20 | 1988-01-07 | Nippon Iyakuhin Kogyo Kk | 新規プロスタグランジンe↓1誘導体及びその製法 |
US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
US6531504B2 (en) * | 2001-05-17 | 2003-03-11 | Allergan, Inc. | Prostanoic acid derivatives as agents for lowering intraocular pressure |
CA2450466C (en) * | 2001-06-14 | 2011-07-05 | Allergan, Inc. | 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
-
2004
- 2004-02-06 WO PCT/US2004/003433 patent/WO2004071428A2/en active Application Filing
- 2004-02-06 KR KR1020057014697A patent/KR101077461B1/ko active IP Right Grant
- 2004-02-06 JP JP2006503371A patent/JP5319065B2/ja not_active Expired - Lifetime
- 2004-02-06 NZ NZ541352A patent/NZ541352A/en not_active IP Right Cessation
- 2004-02-06 BR BRPI0407400-9A patent/BRPI0407400A/pt not_active Application Discontinuation
- 2004-02-06 RU RU2005129072/04A patent/RU2336081C2/ru active
- 2004-02-06 MX MXPA05008431A patent/MXPA05008431A/es active IP Right Grant
- 2004-02-06 AU AU2004211936A patent/AU2004211936B2/en not_active Ceased
- 2004-02-06 CA CA2515631A patent/CA2515631C/en not_active Expired - Fee Related
- 2004-02-06 EP EP04709028A patent/EP1608309B1/en not_active Expired - Lifetime
- 2004-02-06 PL PL378421A patent/PL209130B1/pl unknown
-
2005
- 2005-08-01 NO NO20053715A patent/NO334659B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20050101202A (ko) | 2005-10-20 |
RU2005129072A (ru) | 2006-02-27 |
KR101077461B1 (ko) | 2011-10-26 |
JP5319065B2 (ja) | 2013-10-16 |
EP1608309B1 (en) | 2012-07-11 |
WO2004071428A2 (en) | 2004-08-26 |
NO20053715L (no) | 2005-10-27 |
WO2004071428A3 (en) | 2005-11-10 |
NO334659B1 (no) | 2014-05-12 |
AU2004211936B2 (en) | 2008-09-11 |
BRPI0407400A (pt) | 2006-02-21 |
PL378421A1 (pl) | 2006-04-03 |
EP1608309A2 (en) | 2005-12-28 |
NZ541352A (en) | 2007-12-21 |
MXPA05008431A (es) | 2005-10-19 |
JP2006517587A (ja) | 2006-07-27 |
RU2336081C2 (ru) | 2008-10-20 |
CA2515631C (en) | 2013-08-20 |
CA2515631A1 (en) | 2004-08-26 |
PL209130B1 (pl) | 2011-07-29 |
AU2004211936A1 (en) | 2004-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053715D0 (no) | 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk | |
ZA200505728B (en) | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure | |
DK1503984T3 (da) | 8-azaprostaglandin-analoger som midler til sænkning af intraokulært tryk | |
NO20041567L (no) | 1,8-nafthyridinderivater som antidiabetiske midler | |
DK1638928T3 (da) | N-alkynyl-2-(substituerede aryloxy)alkylthio-amidderivater som fungicider | |
NO20052993D0 (no) | 4,5-diaryltiazolderivater som CB-1 ligander. | |
NO20053775D0 (no) | Diazepinoindol derivater som kinaseinhibitorer. | |
DK1592457T3 (da) | Folat-vinblastin-konjugat som lægemiddel | |
DK1414803T3 (da) | Pyrazolylcarboxanilider som fungicider | |
NO20052884D0 (no) | Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. | |
DK1317431T3 (da) | Polyarylcarboxamider, der er anvendelige som lipidsænkende midler | |
NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
ATE363463T1 (de) | 2-(2,6-dichlorphenyl)-diarylimidazole | |
DK1492786T3 (da) | Pyridinoylpiperidiner som 5-HT1F-agonister | |
IS8509A (is) | Ný 2-heteróarýl-setin bensímídasól afleiða | |
NO20043022L (no) | 5,6-diaryl-pyrazin-2-amid-derivater som CB1-antagonister | |
NO20051688D0 (no) | Farmasoytiske blandinger som har en modifisert baerer | |
NO20053099D0 (no) | Fremgangsmate for a fremstille optisk rene aktive forbindelser. | |
NO20033618L (no) | Ftalayinon-piperidino-derivater som PDE-4-inhibitorer | |
NO20054169D0 (no) | 3-(1-[3-(1,3-benzotiazol-6-yl) propylkarbamoyl]sykloalkyl]propansyrederivater som NEP-inhibitorer. | |
DK1456206T3 (da) | Azaindolylalkylaminderivater som 5-hydroxytryptamin-6-ligander | |
DK1455779T3 (da) | Indolylalkylaminderivater som 5-hydroxytryptamin-6-ligander | |
DK1575948T3 (da) | Pyridodiaziner som plantefungicider | |
DK1231211T3 (da) | Thiazolidindion-derivater som antidiabetika | |
IL182314A0 (en) | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |